Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06709833

Meningioma and Embolism Thrombosis Risk & Investigation of Coagulation

Despite being generally benign tumors, meningiomas are associated with an increased risk for thrombembolic complications after surgical resection. The molecular mechanisms underlying this circumstance are still unknown.

In this prospective observational trial, the investigators aim to evaluate the changes in coagulation and platelet function caused by tumor resection.

Blood samples are obtained by patients undergoing meningioma resection before and immediately after resection to detect said changes.

As a control cohort, blood samples are obtained from patients undergoing resection for glioma.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Meningeoma Surgical Resection Thrombembolism

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital for Anaesthesiology and Intensive Care Medicine, Tuebingen

Tübingen, Baden-Wurttemberg, 72076, Germany

Location status: Recruiting

Location contact

Alice Bernard, MD

CONTACT

[email protected]

0049-7071-2968029

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients undergoing resection for meningioma or
  • Patients undergoing resection for glioma or
  • Healthy controls
  • written consent for study participation

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. Tissue factor

    Time frame: duration of surfical tumor resection (a few hours)

    Concentration of tissue factor at pre-surgery and immediately after tumor resection (during close-up).

Study contacts

Contact information is provided by the study sponsor or research team.

Alice Bernard, MD

CONTACT

[email protected]

+4970712968028

Michael Koeppen, MD

CONTACT

[email protected]

+4970712986935

Sponsors and collaborators

Lead sponsor

University Hospital Tuebingen

Other

Registry information

Acronym: 001_2024_BO2

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Nov 29, 2024
Registry last updated
Jan 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.